Eczema. Atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 18 years old Men and women or older One or more eczema lesions Patients who have not received topical, oral, or injectable medication for the treatment of eczema in the last week Lack of infection or malignancy at the treatment site (no problem with closed wounds) Patient's consent to participate in the study
Exclusion criteria
Exclusion criteria: Under 12 years old Pregnancy and lactation Patients with other skin lesions Patients taking immunosuppressive systemic drugs or biological drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atopic dermatitis disease intensity. Timepoint: At the beginning of the study and about 30 days after starting the topical cream (after treatment). Method of measurement: SCORAD Index form.;Duration of recovery. Timepoint: About 30 days after starting the topical cream (after treatment). Method of measurement: Patient Tracking and Evaluation with SCORAD and DLQI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of dermatology patient's life. Timepoint: At the beginning of the study and about 30 days after starting the topical cream (after treatment). Method of measurement: DLQI questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences